Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY23
Investor Presentation
Q1 FY22
Investor Presentation
Q4 FY21
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY21
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY21
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Eiko Lifesciences Ltd (EIKO) is currently trading at 50.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Eiko Lifesciences Limited specializes in manufacturing and exporting specialty chemicals and pharma intermediates, serving both Indian and global markets. Originally founded as Narendra Investments (Delhi) Limited, the company shifted to its current name and business focus in 2021, marking a significant transformation. Since commencing specialty and fine chemicals production in 2020, Eiko has rapidly scaled operations and expanded its brand and customer base, emerging as a fast-growing player in India. In 2022, Eiko launched new molecules targeting agrochemical intermediates, polymer science, and pharmaceuticals, showcasing its innovation capabilities. The company diversified into applications for agrochemical, personal care, and food industries in 2023, broadening its product range.
Over the past 52 weeks, Eiko Lifesciences Ltd has traded between a low of ₹46.49 and a high of ₹65.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Eiko Lifesciences Ltd has a market capitalization of approximately 71.74. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Eiko Lifesciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.95 and operates in the Chemicals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 71.74 Cr, Eiko Lifesciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Eiko Lifesciences Ltd operates in the Chemicals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Eiko Lifesciences Ltd is 15.95. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
5
Neutral
5
Bullish
4
Bearish
37
Neutral
5
Bullish
4
Bearish
32
Neutral
0
Bullish
0
Substantial Acquisition
Eiko Lifesciences promoter Bhavesh D. Tanna was allotted 450,000 equity shares and 1,550,000 preferential warrants (conversion rights) on Feb 26, 2026, raising his holding to 840,000 (5.86% non‑diluted; 4.86% diluted) and to 2,390,000 (13.82%) upon full conversion of warrants.
Substantial Acquisition
On 26 Feb 2026 Bhavesh Dhirajlal Tanna (promoter) was allotted 450,000 equity shares and 1,550,000 preferential warrants of Eiko Lifesciences (Scrip:540204); post‑allotment holding 840,000 shares (5.86% non‑diluted) and potential 2,390,000 shares (13.82%) on conversion.
Regulation 29 Disclosure
Lenus Finvest Pvt Ltd (promoter group) was allotted 175,000 equity shares (1.22% non‑diluted) and 150,000 preferential warrants by Eiko Lifesciences on 24 Feb 2026, raising its aggregate stake to 2,540,472 shares (17.71% non‑diluted).
Eiko Lifesciences Limited specializes in manufacturing and exporting specialty chemicals and pharma intermediates, serving both Indian and global markets.
Originally founded as Narendra Investments (Delhi) Limited, the company shifted to its current name and business focus in 2021, marking a significant transformation.
Since commencing specialty and fine chemicals production in 2020, Eiko has rapidly scaled operations and expanded its brand and customer base, emerging as a fast-growing player in India.
In 2022, Eiko launched new molecules targeting agrochemical intermediates, polymer science, and pharmaceuticals, showcasing its innovation capabilities.
The company diversified into applications for agrochemical, personal care, and food industries in 2023, broadening its product range.
Chemicals
Chemicals - Speciality - Medium / Small
72 Cr
Low Risk
15.9
25.5
0.5
1.2
65.90
46.49
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
92.15 | 100 Cr | 16.79 | 2.76 | 0.00 | 32.00 | 30.57 | 0.00 | |
18.96 | 98 Cr | 24.62 | 1.68 | 3.12 | 7.13 | 9.02 | 3.97 | |
43.70 | 89 Cr | 14.47 | 1.00 | 0.00 | 6.79 | 8.81 | 5.95 | |
1951.15 | 88 Cr | 4.22 | 1.84 | 0.91 | 12.37 | 18.78 | 54.83 | |
44.90 | 78 Cr | 14.82 | 1.71 | 0.00 | 6.64 | 7.76 | 4.18 | |
31.63 | 76 Cr | 15.50 | 0.81 | 0.00 | 5.34 | 7.69 | 3.49 | |
50.00 | 72 Cr | 15.95 | 1.15 | 0.00 | 5.86 | 9.30 | 7.71 |
